Puma Biotechnology
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology
Puma Biotech plunges on drug side effects
Puma Biotechnology
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Jobs with Puma Biotechnology
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Inc
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotechnology and Bixink Therapeutics Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in South Korea | Business Wire
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotechnology
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in China - Los Angeles Business Journal
